Appendix - Appendix

Section CSB 2.01 - Addition of methaqualone to schedule II
Section CSB 2.02 - Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III
Section CSB 2.03 - Addition of fenfluramine to schedule IV
Section CSB 2.04 - Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III
Section CSB 2.05 - Addition of drotebanol to schedule I
Section CSB 2.06 - Addition of pentazocine to schedule III
Section CSB 2.07 - Transfer of hydrochloride form of etorphine from schedule I to schedule II
Section CSB 2.08 - Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV
Section CSB 2.09 - Additions to schedules IV and I
Section CSB 2.10 - Addition of propiram to schedule I
Section CSB 2.11 - Renumbering and addition to schedule IV of diethylpropion and phentermine
Section CSB 2.13 - Addition of dextropropoxyphene to schedule IV
Section CSB 2.14 - Addition of prazepam to schedule IV
Section CSB 2.15 - Addition of parahexyl to schedule I; removal of loperamide from schedule V; addition of triazolam to schedule IV
Section CSB 2.16 - Transfer of sufentanil from schedule I to schedule II
Section CSB 2.17 - Addition of buprenorphine to schedule V; transfer of methaqualone from schedule II to schedule I; transfer of dronabinol from schedule I to schedule II
Section CSB 2.18 - Addition of 3,4-methylenedioxymethamphetamine to schedule I
Section CSB 2.19 - Additions, deletions and transfers to statutory schedules
Section CSB 2.20 - Addition of beta-hydroxy-3-methylfentanyl to schedule I
Section CSB 2.21 - Additions, deletions, corrections, transfers, and amendments to drug schedules
Section CSB 2.22 - Additions to drug schedules
Section CSB 2.23 - Additions and amendments to drug schedules
Section CSB 2.24 - Addition of butorphanol to schedule IV
Section CSB 2.25 - Addition of remifentanil to schedule II; transfer of dronabinol from schedule II to schedule III; addition of fenproporex, modafinil, sibutramine, zaleplon and zolpidem to schedule IV; spelling correction of carfentanil
Section CSB 2.26 - Addition of dihydroetorphine to schedule II
Section CSB 2.28 - Addition of dichloralphenazone to schedule IV
Section CSB 2.29 - Transfer of buprenorphine from schedule V to schedule III
Section CSB 2.30 - Addition of gamma-hydroxybutyric acid to schedule III
Section CSB 2.31 - Addition of 2,5 dimethoxy-4-(n)- propylthiophenethylamine (2C-T-7) to schedule I
Section CSB 2.32 - Addition of N- benzylpiperazine (BZP) to schedule I
Section CSB 2.33 - Addition of alpha-methyltryptamine (AMT) to schedule I
Section CSB 2.34 - Addition of 5-methoxy-N, N-diisopropyltryptamine (5-MeO-DIPT)
Section CSB 2.35 - Addition of lisdexamfetamine to schedule II
Section CSB 2.36 - Addition of tramadol to schedule IV
Section CSB 2.37 - Rescheduling of hydrocodone combination products
Section CSB 2.38 - Addition of suvorexant to schedule IV
Section CSB 2.39 - Exclusion of naloxegol
Section CSB 2.40 - Exclusion of [123I] ioflupan
Section CSB 2.41 - Scheduling of beta-hydroxythiofentanyl and butyryl fentanyl
Section CSB 2.42 - Scheduling of furanyl fentanyl
Section CSB 2.43 - Addition of brivaracetam to schedule V
Section CSB 2.44 - Addition of thiafentanil to schedule II
Section CSB 2.45 - Addition of AB-FUBINACA and ADB-PINACA to schedule I
Section CSB 2.46 - Addition of acetyl fentanyl to schedule I
Section CSB 2.47 - Addition of AH-7921 to schedule I
Section CSB 2.48 - Addition of eluxadoline to schedule IV
Section CSB 2.49 - Addition of U-47700 to schedule I
Section CSB 2.50 - Addition of AB-CHMINACA, AB-PINACA and THJ-2201 to schedule I
Section CSB 2.51 - Addition of MAB-CHMINACA to schedule I
Section CSB 2.52 - Addition of 4-MePPP and a-PBP to schedule I
Section CSB 2.53 - Scheduling of acryl fentanyl
Section CSB 2.54 - Addition of oral solutions containing dronabinol to schedule II
Section CSB 2.55 - Addition of 5F-ADB, 5F-AMB, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA to schedule I
Section CSB 2.56 - Addition of 4-fluoroisobutyryl fentanyl to schedule I
Section CSB 2.57 - Scheduling of cyclopropyl fentanyl
Section CSB 2.58 - Exclusion of naldemedine
Section CSB 2.59 - Addition of ortho-fluorofentanyl to schedule I
Section CSB 2.60 - Addition of FUB-AMB to schedule I
Section CSB 2.61 - Addition of MT-45 to schedule I
Section CSB 2.62 - Addition of para-chloroisobutyryl fentanyl to schedule I
Section CSB 2.63 - Addition of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA to schedule I
Section CSB 2.64 - Addition of N-Ethylpentylone to schedule I
Section CSB 2.65 - Addition of approved cannabidiol drugs to schedule V
Section CSB 2.66 - Addition of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 to schedule I
Section CSB 2.67 - Addition of Brexanolone and Solriamfetol to schedule IV
Section CSB 2.68 - Addition of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8 and 4-chloro-a-PVP to schedule I
Section CSB 2.69 - Addition of Noroxymorphone to schedule II
Section CSB 2.70 - Scheduling 4F-MDMB-BINACA and MMB-FUBICA
Section CSB 2.71 - Addition of lasmiditan to schedule V
Section CSB 2.72 - Scheduling of isotonitazene and 1P-LSD
Section CSB 2.73 - Addition of cenobamate to schedule V
Section CSB 2.74 - Addition of Lemborexant to schedule IV
Section CSB 2.75 - Exclusion of approved cannabidiol drugs from schedule I
Section CSB 2.76 - Addition of norfentanyl to schedule II
Section CSB 2.77 - Scheduling of flualprazolam
Section CSB 2.78 - Addition of crotonyl fentanyl to schedule I
Section CSB 2.79 - Addition of remimazolam to schedule IV
Section CSB 2.80 - Scheduling of oliceridine
Section CSB 2.81 - Addition of brorphine to schedule I
Section CSB 2.82 - Addition of Serdexmethylphenidate to schedule IV
Section CSB 2.83 - Addition of ten (10) fentanyl-related substances to schedule I
Section CSB 2.84 - Addition of alfaxalone to schedule IV
Section CSB 2.85 - Excluding 6-beta-naltrexol from schedule II
Section CSB 2.86 - Addition of fospropofol to schedule IV
Section CSB 2.87 - Addition of embutramide to schedule III
Section CSB 2.88 - Addition of lacosamide to schedule V
Section CSB 2.89 - Addition of perampanel to schedule III
Section CSB 2.90 - Transfer of 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile, immediate precursors to phencyclidine, also known as PCP, from Schedule I to schedule II
Section CSB 2.91 - Addition of 4,4'-Dimethylaminorex to schedule I
Section CSB 2.92 - [Repealed]
Section CSB 2.93 - [Repealed]
Section CSB 2.94 - [Repealed]
Section CSB 2.95 - [Repealed]
Section CSB 2.96 - Addition of Amineptine to schedule I
Section CSB 2.97 - Addition of Zipeprol to schedule I
Section CSB 2.98 - xcluding [[18]F] FP-CIT from schedule II
Section CSB 2.99 - Addition of Mesocarb to schedule I